"Chelation Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.
| Descriptor ID |
D015913
|
| MeSH Number(s) |
E02.319.155
|
| Concept/Terms |
Chelation Therapy- Chelation Therapy
- Therapy, Chelation
- Chelation Therapies
- Therapies, Chelation
|
Below are MeSH descriptors whose meaning is more general than "Chelation Therapy".
Below are MeSH descriptors whose meaning is more specific than "Chelation Therapy".
This graph shows the total number of publications written about "Chelation Therapy" by people in this website by year, and whether "Chelation Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 0 | 7 | 7 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chelation Therapy" by people in Profiles.
-
SARS-CoV-2 infection in patients with ß-thalassemia: Experience from Lebanon. Am J Hematol. 2021 08 01; 96(8):E285-E288.
-
SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19. Immunobiology. 2021 01; 226(1):152021.
-
Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic. Blood. 2020 06 18; 135(25):2320-2322.
-
Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus. J Pak Med Assoc. 2020 May; 70(Suppl 3)(5):S69-S73.
-
Melatonin: A hypothesis regarding its use to treat Wilson disease. Med Hypotheses. 2019 Dec; 133:109408.
-
The Role of Deferiprone in Iron Chelation. N Engl J Med. 2019 02 28; 380(9):891-892.
-
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias. Health Qual Life Outcomes. 2018 Nov 19; 16(1):216.
-
[Hyperphosphatemia in dialysis: which binder?] G Ital Nefrol. 2018 Sep; 35(5).
-
Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes. Eur J Haematol. 2018 Sep; 101(3):272-282.
-
Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer. 2018 10 15; 124(20):3979-3989.